233 related articles for article (PubMed ID: 10692777)
21. [Azathioprine in inflammatory bowel disease].
Leite S; Ribeiro JM; Lima SC; Barroso S; Cotter J
Acta Med Port; 2009; 22(1):33-40. PubMed ID: 19341591
[TBL] [Abstract][Full Text] [Related]
22. [Therapy of chronic inflammatory bowel diseases with azathioprine, 6-mercaptopurine and 6-thioguanine. Clinico-pharmacologic aspects].
Schwab M; Herrlinger K; Schaeffeler E; Stange EF
Dtsch Med Wochenschr; 2003 Feb; 128(8):378-85. PubMed ID: 12594624
[No Abstract] [Full Text] [Related]
23. Recent advances using immunomodulators for inflammatory bowel disease.
Nielsen OH; Bjerrum JT; Herfarth H; Rogler G
J Clin Pharmacol; 2013 Jun; 53(6):575-88. PubMed ID: 23408468
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of thiopurinic immunomodulators (azathioprine and mercaptopurine) in steroid-dependent ulcerative colitis.
Lopez-Sanroman A; Bermejo F; Carrera E; Garcia-Plaza A
Aliment Pharmacol Ther; 2004 Jul; 20(2):161-6. PubMed ID: 15233695
[TBL] [Abstract][Full Text] [Related]
25. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
Roblin X; Serre-Debeauvais F; Phelip JM; Faucheron JL; Hardy G; Chartier A; Helluwaert F; Bessard G; Bonaz B
Aliment Pharmacol Ther; 2005 Apr; 21(7):829-39. PubMed ID: 15801918
[TBL] [Abstract][Full Text] [Related]
26. The use of 6-mercaptopurine in patients with inflammatory bowel disease after failure of azathioprine therapy.
Boulton-Jones JR; Pritchard K; Mahmoud AA
Aliment Pharmacol Ther; 2000 Dec; 14(12):1561-5. PubMed ID: 11121903
[TBL] [Abstract][Full Text] [Related]
27. Optimising outcome on thiopurines in inflammatory bowel disease by co-prescription of allopurinol.
Smith MA; Blaker P; Marinaki AM; Anderson SH; Irving PM; Sanderson JD
J Crohns Colitis; 2012 Oct; 6(9):905-12. PubMed ID: 22386736
[TBL] [Abstract][Full Text] [Related]
28. Thiopurines in Crohn's disease, is there something new?
Miheller P; Lakatos PL
Expert Opin Drug Metab Toxicol; 2010 Dec; 6(12):1505-14. PubMed ID: 20919963
[TBL] [Abstract][Full Text] [Related]
29. A report on efficacy and safety of azathioprine in a group of inflammatory bowel disease patients in northwest Greece.
Christodoulou D; Katsanos K; Baltayannis G; Tzabouras N; Tsianos EV
Hepatogastroenterology; 2003; 50(52):1021-4. PubMed ID: 12845970
[TBL] [Abstract][Full Text] [Related]
30. [Optimization of immunomodulatory treatment with azathioprine or 6-mercaptopurine in inflammatory bowel disease].
Bastida Paz G; Nos Mateu P; Aguas Peris M; Beltrán Niclós B; Rodríguez Soler M; Ponce García J
Gastroenterol Hepatol; 2007 Nov; 30(9):511-6. PubMed ID: 17980127
[TBL] [Abstract][Full Text] [Related]
31. [Immunosuppressive treatment of ulcerative colitis].
Shiratori T; Katsumata S; Miyaoka M; Saito T
Nihon Rinsho; 1999 Nov; 57(11):2486-9. PubMed ID: 10572417
[TBL] [Abstract][Full Text] [Related]
32. Tolerability and usefulness of mercaptopurine in azathioprine-intolerant Japanese patients with ulcerative colitis.
Kuriyama M; Kato J; Suzuki H; Akita M; Hiraoka S; Okada H; Yamamoto K
Dig Endosc; 2010 Oct; 22(4):289-96. PubMed ID: 21175481
[TBL] [Abstract][Full Text] [Related]
33. Pancreatitis in inflammatory bowel diseases.
Pitchumoni CS; Rubin A; Das K
J Clin Gastroenterol; 2010 Apr; 44(4):246-53. PubMed ID: 20087199
[TBL] [Abstract][Full Text] [Related]
34. [Questions and answers on the role of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel disease].
Gisbert JP; Gomollón F; Maté J; Pajares JM
Gastroenterol Hepatol; 2002; 25(6):401-15. PubMed ID: 12069704
[No Abstract] [Full Text] [Related]
35. Mercaptopurine and inflammatory bowel disease: the other thiopurine.
Bermejo San José F; Algaba A; López Durán S; Guerra I; Aicart M; Hernández-Tejero M; Garrido E; de Lucas M; Bonillo D; López Sanromán A
Rev Esp Enferm Dig; 2017 Jan; 109(1):10-16. PubMed ID: 27809554
[TBL] [Abstract][Full Text] [Related]
36. [Immunodepressants in the treatment of Crohn's disease and non-specific ulcerative colitis].
Radbil' OS
Klin Med (Mosk); 1976 Mar; 54(3):8-14. PubMed ID: 787661
[No Abstract] [Full Text] [Related]
37. Efficacy and safety of azathioprine and 6-mercaptopurine in Japanese pediatric patients with ulcerative colitis: a survey of the Japanese Society for Pediatric Inflammatory Bowel Disease.
Tajiri H; Tomomasa T; Yoden A; Konno M; Sasaki M; Maisawa S; Sumazaki R; Shimizu T; Toyoda S; Etani Y; Nakacho M; Ushijima K; Kobayashi A;
Digestion; 2008; 77(3-4):150-4. PubMed ID: 18577852
[TBL] [Abstract][Full Text] [Related]
38. Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine.
Su C; Lichtenstein GR
Gastroenterol Clin North Am; 2004 Jun; 33(2):209-34, viii. PubMed ID: 15177535
[TBL] [Abstract][Full Text] [Related]
39. Medical management of patients with difficult-to-treat inflammatory bowel disease.
van Hogezand RA
Neth J Med; 1994 Aug; 45(2):55-9. PubMed ID: 7936006
[TBL] [Abstract][Full Text] [Related]
40. Routinely Established Skewed Thiopurine Metabolism Leads to a Strikingly High Rate of Early Therapeutic Failure in Patients With Inflammatory Bowel Disease.
Kreijne JE; Seinen ML; Wilhelm AJ; Bouma G; Mulder CJ; van Bodegraven AA; de Boer NK
Ther Drug Monit; 2015 Dec; 37(6):797-804. PubMed ID: 25853923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
